Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Download a free pdf of pharma and healthcare insight

Pharma and Healthcare market data, analysis and forecasts from Business Monitor International, the trusted source for business information and industry intelligence across global markets.

Pharma and Healthcare Insight provides market intelligence, trend analysis, forecasts and ratings for the global Pharma and Healthcare industry on a country-by-country basis across the Americas, Emerging Europe, Western Europe, Asia, and the Middle East & Africa. Combined with competitive intelligence on the growth strategies of the leading national and multinational companies, Pharma and Healthcare Insight allows you track key developments across the global Pharma and Healthcare industry.

Subscribers receive password access to the latest intelligence, a searchable 24-month archive of Pharma and Healthcare Insight articles and data plus the ability to download PDFs of current and back issues.

›› To gain FREE online access for 14 days and to download a FREE PDF, click trial.

›› To receive 15 monthly pdf issues for the price of 12 and to gain immediate online access, click subscribe.

  To access our feed of headlines copy this link to your RSS reader

follow pharma and healthcare insight on twitter  Follow Pharma and Healthcare Insight on Twitter

Latest Stories

Industry / United States

BMI View: If successfully developed and marketed, Bristol-Myer Squibb (BMS)'s investigational combination immuno-oncology therapy will potentially be a leader in the market for skin cancer treatments, outperforming similar medicines from Merck & Co and Roche. However, although anticipation of positive trial results from the combination therapy is improving investor confidence,... 2013-05-20

Industry / Ecuador

BMI View: The steadily growing Ecuadorian pharmaceutical market will provide revenue-earning opportunities for Takeda. However, the limited market size and low per capita spending on... 2013-03-22


BMI View: Despite the undoubted clinical and commercial success of traditional chemotherapy, demand for new targeted cancer therapies is likely to remain high. This will provide continued... 2013-03-22


Industry / South Korea

The halt of yet another clinical trial for a biosimilar of Roche's Rituxan (rituximab) highlights the regulatory issues biosimilars are currently experiencing. The delay will benefit biologics manufacturers such as Roche, as their market shares will threatened by biosimilars but remain relatively secure for now.


Industry / Japan

Through their involvement in this growing trend, Shionogi, Daiichi Sankyo, Astellas Pharma, Takeda and Eisai can expect to reap huge reputational benefits, as well as access to knowledge... 2013-04-26

Industry / Myanmar

We highlight the difficulty Myanmar will face in healthcare financing, given the country's high burden of communicable and non-communicable diseases. The situation is made worse by... 2013-04-25

Emerging Europe

Industry / Russia

The Federal Antimonopoly Service's decision, to block a proposed merger between Abbott Laboratories Petrovax Pharm, while unexpected, does not signal a worsening investment climate in Russia. The country's proximity to the Asia-Pacific region, and seasonal flu pandemics, have influenced the FAS's desire to protect vaccine production in Russia. We note that there is a strong precedence... 2013-04-22

Industry / Ukraine

BMI View: The announcement by the health minister that compulsory health insurance is unlikely to be rolled out in the short term is disappointing but not unexpected, given the country's... 2013-04-10

Industry / Ukraine

BMI View: Although largely regressive, the impact of the government's move to limit medicine procurement to domestic production will be low, given the small scale of state drug expenditure... 2013-04-09

Middle East & Africa

Industry / Nigeria

BMI View: Medicines demand in Nigeria will be driven by urbanisation, rising per capita incomes, a growing burden on non-communicable diseases and the government's plans to increase widespread healthcare access to all citizens. However, we note that government spending is significantly dependent on oil and gas revenues and, as such, any fall in prices of these commodities is likely... 2013-10-09

Industry / Nigeria

BMI View: Medicines demand in Nigeria will be driven by urbanisation, rising per capita incomes, a growing burden on non-communicable diseases and the government's plans to increase... 2013-10-09

Industry / United Arab Emirates

The demographic profile of the emirate of Dubai is not conducive to widespread healthcare insurance uptake. The population is young – with 50% of residents between the ages... 2013-10-07

Western Europe


GlaxoSmithKline (GSK) is a leading global manufacturer of prescription medicines and consumer healthcare products. The company has offices in over 100 countries and major research centres in the UK, US, Belgium and China. GSK's shares are listed on the London and New York Stock Exchanges and its corporate head office is located in the


Industry / Italy

BMI View: Governments across Europe are focussing on cost containment. The consequent scrutiny on drug prices and medicine consumption will subsequently put pressure on companies and... 2013-02-22

Industry / Switzerland

BMI View: Novartis' U-turn over CEO Daniel Vasella's exit package could fuel support for a March 3 2013 referendum in Switzerland that proposes changes to Swiss corporate laws, including... 2013-02-20